T
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 8-K13.6 KBTrubion Pharmaceuticals, IncJun 1, 4:01 PM ET·0000950123-10-054728
- 8-K18.1 KBTrubion Pharmaceuticals, IncJun 19, 4:03 PM ET·0001299933-08-003078
- 8-K8.6 KBTrubion Pharmaceuticals, IncSep 20, 2:42 PM ET·0000950134-07-020252
- 10-Q297.4 KBTrubion Pharmaceuticals, IncAug 13, 4:12 PM ET·0000950134-07-018044
- 8-K39.4 KBTrubion Pharmaceuticals, IncAug 13, 4:02 PM ET·0000950134-07-018041
- 10-K1.2 MBTrubion Pharmaceuticals, IncMar 26, 4:51 PM ET·0000891020-07-000078
- 8-K48.2 KBTrubion Pharmaceuticals, IncMar 26, 4:01 PM ET·0000950134-07-006579
- S-1/A2.2 MBTrubion Pharmaceuticals, IncOct 5, 5:17 PM ET·0000891020-06-000270
- S-1/A2.6 MBTrubion Pharmaceuticals, IncSep 22, 5:18 PM ET·0000891020-06-000260
- S-1/A2.3 MBTrubion Pharmaceuticals, IncAug 18, 4:43 PM ET·0000950124-06-004685
Insiders
10- ARCH V ENTREPRENEURS FUND LP10% Owner
- ARCH VENTURE FUND V LP10% Owner
- Bencich JohnV.P. and CFO
- BYBEE CLINTON10% Owner
- CRANDELL KEITH10% Owner
- GRIFFIN MICHELLE RENEESenior V.P. and C.O.O.
- MCKEREGHAN KATHLEENSVP and General Counsel
- Mohler KendallSVP & Chief Scientific Officer
- NELSEN ROBERT10% Owner
- STROMATT SCOTTSVP and Chief Medical Officer
Tickers
No tickers on record
Addresses
business
2401 4TH AVENUE SUITE 1050
SEATTLE, WA, 98121
mailing
2401 4TH AVENUE SUITE 1050
SEATTLE, WA, 98121